All Stories

  1. Association of Bassoon ( BSN ) Gene Mutations With Gait and Motor Impairments in Parkinson's Disease
  2. Progressive Supranuclear Palsy in India: Insights from a Large Multicenter Clinical Cohort (Project PAIR-PSP)
  3. Practices, Resources and Challenges in Parkinson's Disease Management in Asia: Movement Disorders in Asia Study Group Report
  4. Progressive Supranuclear Palsy—A Global Review
  5. Association of Bassoon (BSN) Gene Mutations with Gait and Motor Impairments in Parkinson's Disease
  6. Preface to the Sixth MDS Video Challenge Case Supplement for Movement Disorders Clinical Practice
  7. Can simple home-based exercises reduce the fear of falling in Parkinsonian disorders?
  8. Bassoon, Presynaptic Scaffolding Protein: Narrative Review in Health and Disease
  9. Bassoon, Presynaptic scaffolding protein: Narrative Review in Health and Disease
  10. Levodopa Equivalent Daily Dosage: Geographical Variations and Real‐Life Modules in Parkinson's Disease
  11. Exercise Habits in People with Parkinson's: A Multinational Survey
  12. Movement Disorders in Patients with Subacute Sclerosing Panencephalitis: A Systematic Review
  13. The Genetic Drivers of Juvenile, Young, and Early‐Onset Parkinson's Disease in India
  14. Safety and tolerability of long-term apomorphine infusion in advanced Parkinson's disease: an Indian multi-center (APO-IND) experience
  15. Continuous Subcutaneous Infusion Delivery of Apomorphine in Parkinson's Disease: A Systematic Review
  16. The genetic drivers of juvenile, young, and early-onset Parkinson’s Disease in India
  17. Genetic Movement Disorders Commonly Seen in Asians
  18. Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals
  19. iSTIMULI: Prescriptive Stimulus Design for Eye Movement Analysis of Patients with Parkinson’s Disease
  20. Underrepresented Populations in Parkinson's Genetics Research: Current Landscape and Future Directions
  21. Genome‐Wide Polygenic Score Predicts Large Number of High Risk Individuals in Monogenic Undiagnosed Young Onset Parkinson's Disease Patients from India
  22. Oculogyric Crisis Phenotype of Levodopa‐Induced Ocular Dyskinesia
  23. COVID-19: The cynosure of rise of Parkinson's disease
  24. The Spectrum of Movement Disorders in Tertiary Care Centers in India
  25. Wilson's Disease Update
  26. Cross-sectional analysis of the Parkinson’s disease Non-motor International Longitudinal Study baseline non-motor characteristics, geographical distribution and impact on quality of life
  27. Chorea-acanthocytosis
  28. PRRT2 Gene Mutations in Indian Paroxysmal Kinesigenic Dyskinesia Patients
  29. Gastrointestinal dysfunction in Parkinson’s disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation
  30. Hypoparathyroidism Masquerading as Corticobasal Syndrome
  31. Clinical Study of 668 Indian Subjects with Juvenile, Young, and Early Onset Parkinson’s Disease
  32. GP2: The Global Parkinson's Genetics Program
  33. Impact of home confinement during COVID-19 pandemic on sleep parameters in Parkinson's disease
  34. Huntington’s disease
  35. Reply to: Fatal Familial Insomnia: A Rare Disease with Unique Clinico‐Neurophysiological Features
  36. Impact of home confinement during COVID-19 pandemic on Parkinson's disease
  37. Does Apomorphine Have an Effect on Body Weight? An Observational Study
  38. A Case of Autosomal Dominant Ataxia with Vocal Cord Palsy Attributed to a Mutation in the PRNP Gene
  39. Genetic Architecture of Parkinson's Disease in the Indian Population: Harnessing Genetic Diversity to Address Critical Gaps in Parkinson's Disease Research
  40. Looking beyond the fog—apomorphine demystified
  41. Subcutaneous apomorphine in advanced Parkinson’s disease and its use in Indian population
  42. Apomorphine: The initial indian experience in relation to response tests and pumps
  43. The chronicles of modern movement disorders in India
  44. Wilson's Disease: Clinical Practice Guidelines of the Indian National Association for Study of the Liver, the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition, and the Movement Disorders Society of India
  45. Surgical treatment of dystonia
  46. First Case report of PARK 9 from India
  47. Minimal change multiple system atrophy: An aggressive variant?
  48. Over-the-counter self-medication leading to intracranial hypertension in a young lady
  49. Amantadine improves gait in PD patients with STN stimulation
  50. Reply to letter: multiple system atrophy-parkinsonism with slow progression and prolonged survival: A diagnostic catch
  51. A randomized trial of varenicline (chantix) for the treatment of spinocerebellar ataxia type 3
  52. Psychogenic facial movement disorders: Clinical features and associated conditions
  53. Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic
  54. Multiple system atrophy-parkinsonism with slow progression and prolonged survival: A diagnostic catch
  55. Extreme task specificity: Is it dystonia or another form of motor programming abnormality?
  56. Brain Activation Studies in Parkinson’s Disease
  57. l-Dopa-Induced Dyskinesia—Clinical Presentation, Genetics, and Treatment
  58. Spectrum of epilepsy in Wilson's disease with electroencephalographic, MR imaging and pathological correlates
  59. Do MRI features distinguish Wilson's disease from other early onset extrapyramidal disorders? An analysis of 100 cases
  60. Wilson’s disease: 31P and 1H MR spectroscopy and clinical correlation
  61. Wilson′s disease : An Indian perspective
  62. Dominant psychiatric manifestations in Wilson's disease: A diagnostic and therapeutic challenge!
  63. Psychiatric Manifestations in Wilson's Disease: A Cross-Sectional Analysis
  64. Quality of life in Wilson′s disease
  65. Central Pontine Signal Changes in Wilson's Disease: Distinct MRI Morphology and Sequential Changes with De-Coppering Therapy
  66. Sequential MRI changes in Wilson's disease with de-coppering therapy: a study of 50 patients
  67. Subacute Sclerosing Panencephalitis (SSPE): An Insight Into the Diagnostic Errors From a Tertiary Care University Hospital
  68. Long term survival in subacute sclerosing panencephalitis: An enigma
  69. Wilson’s disease: cranial MRI observations and clinical correlation
  70. Adult onset subacute sclerosing panencephalitis: clinical profile of 39 patients from a tertiary care centre
  71. Prognostic factors in patients presenting with severe neurological forms of Wilson's disease
  72. Is low serum tocopherol in Wilson's disease a significant symptom?
  73. Wilson's disease: diagnostic errors and clinical implications
  74. Successful pregnancies and abortions in symptomatic and asymptomatic Wilson's disease